HCN News Team – Page 36 – Highly Capitalized

Thursday, May 14, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry

HCN News Team2025-11-29T16:29:12-08:00November 29th, 2025|Business, Insights|

NEW YORK- The quiet addition of a single paragraph in ...

Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs

HCN News Team2025-11-28T07:07:18-08:00November 28th, 2025|Capital, MSOs|

NEW YORK – Tilray Brands Inc. confirmed it will carry ...

New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients

HCN News Team2025-11-28T04:04:54-08:00November 28th, 2025|Local Politics|

ALBANY – Governor Kathy Hochul signed a bill into law ...

New Brunswick Government Bets on Organigram with $2M Grant

HCN News Team2025-11-27T07:19:01-08:00November 27th, 2025|International|

MONCTON – Organigram Global Inc. has secured $2 million in ...

Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone

HCN News Team2025-11-27T06:21:28-08:00November 27th, 2025|International, Investors|

DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 ...

Medicare Explores CBD Coverage for Seniors

HCN News Team2025-11-27T04:54:01-08:00November 27th, 2025|People|

WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) ...

How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn

HCN News Team2025-11-25T15:36:24-08:00November 25th, 2025|Business, Insights|

LOS ANGELES- Each year, the global Cannabis industry converges on ...

New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program

HCN News Team2025-11-25T07:46:02-08:00November 25th, 2025|Psychedelics|

TRENTON – New Jersey lawmakers advanced a bill that would ...

Week in Review: Cannabis & Psychedelics Industry Highlights

HCN News Team2025-11-25T09:16:11-08:00November 24th, 2025|Business, The Week in Review|

LOS ANGELES – Operators and investors in Cannabis and Psychedelics ...

Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations

HCN News Team2025-11-24T10:30:20-08:00November 21st, 2025|Psychedelics|

BERLIN – Switzerland's long-standing framework for psychedelic treatments has set ...

Previous 353637 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.